On behalf of the organizing committee for the 4th International Conference for HDX-MS, we invite you to sponsor the 2024 conference, held 21-24 April 2024, at the Monterey Conference Center, Monterey, CA, USA. Supporting funds are crucial to this venture's success as they defray expenses for invited speakers and make the meeting affordable to trainees, established researchers, and corporate scientists alike.
This fourth edition of the Conference follows the first three highly successful meetings, the last held in London in 2022. Over 150 participants from industry and academia converged to share the latest HDX-MS technologies and applications. Our focused, intimate, high-level meeting on the topic continues to be met with great enthusiasm and is a highlight conference within the community.
Given the growth in the field of protein structure analysis by HDX-MS, the International Society for HDX-MS, a not-for-profit organization, was established in 2017. This society maintains the Conference's continuity and advocates with a single voice for HDX research.
Our society is proud of the broad representation and diversity it has obtained within such a short time. The fourth edition of the meeting will continue in the vein of attracting all key thought leaders in the field and stimulate the attendance of those wanting to learn more. The 2024 meeting will focus on expanding the applications and utility of HDX-MS from fundamental biological inquiry to biotherapeutics characterization.
We have built a great lineup of high-profile speakers, including Prof. Jane Dyson (The Scripps Research Institute, USA), Prof. John Engen (Northeastern University, Boston, USA), Prof. Patrick Griffin (University of Florida, USA), Prof. Thomas Jørgensen, (University of Southern Denmark, DK). Please see the preliminary program on the conference website http://www.hdxms2024.org/.
Specific details of the sponsorship benefits are on the following pages. We welcome discussion if you have other ideas or needs. The ongoing effects of the pandemic present an unprecedented factor in conference planning. Rest assured that we have suitable contingencies to ensure a successful conference.
Again, thank you for your generous support of the 4th International Conference for HDX-MS.
Sheena D'Arcy, Ph.D.
Associate Professor of Chemistry & Biochemistry
The University of Texas at Dallas
Miklos Guttman, Ph.D.
Associate Professor of Medicinal Chemistry
University of Washington